Loading clinical trials...
Loading clinical trials...
An Exploratory Study of CS-3150 to Evaluate the Relation Between Antihypertensive Effect and Baseline Factors Compared to Olmesartan Medoxomil in Patients With Essential Hypertension
Conditions
Interventions
CS-3150
olmesartan medoxomil
Locations
1
Japan
Tokyo, Japan
Start Date
August 1, 2016
Primary Completion Date
April 1, 2017
Completion Date
April 1, 2017
Last Updated
December 21, 2018
NCT06823947
NCT06604897
NCT07448506
NCT07433790
NCT07421414
NCT07421401
Lead Sponsor
Daiichi Sankyo Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions